FDA recall D-1075-2018

Mylan Pharmaceuticals Inc. · Class II · drug

Product

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

Reason for recall

Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

Distribution

U.S. Nationwide

Key facts

Status
Terminated
Initiation date
2018-07-25
Report date
2018-08-15
Termination date
2019-08-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1075-2018